Tag Archives: Accounting News & Issues

Hansa Biopharma Year-end record January-December 2022 

Complete 2022 earnings of SEK 155m Cash money path expanded right into 2025 Market Gain access to gotten in 4 of the 5 biggest European markets Reported favorable Stage 2 top-line information in AMR Choice made to launch professional research study with imlifidase as a pre-treatment to Sarepta’s SRP-9001 genetics treatment in 2023 LUND, Sweden, Feb. 2, 2023/… Read More »